Loading data
IMMRNasdaq
| Unit: USD | FY2026 | FY2025 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.73 bn USD | 1.56 bn USD | 33.92 m USD | 38.46 m USD | 35.09 m USD |
| Cost of revenue | — | — | — | 4 k USD | 88 k USD |
| Research and development expense | — | — | 281 k USD | 1.38 m USD | 4.15 m USD |
| Operating profit | 25.91 m USD | 118.02 m USD | 17.93 m USD | 24.42 m USD | 17.78 m USD |
| Profit before tax | 26.03 m USD | 119.29 m USD | 42.92 m USD | 26.97 m USD | 17.29 m USD |
| Income tax expense | 16.82 m USD | 25.71 m USD | 8.94 m USD | -3.7 m USD | 4.81 m USD |
| Net income (reported basis) | 4.52 m USD | 64.28 m USD | 33.98 m USD | 30.66 m USD | 12.48 m USD |
| Net income attributable to common shareholders | 4.52 m USD | 62.66 m USD | 33.98 m USD | — | — |
| Basic earnings per share | 0.14 USD/share | 1.94 USD/share | 1.05 USD/share | 0.92 USD/share | 0.4 USD/share |
| Diluted earnings per share | 0.14 USD/share | 1.9 USD/share | 1.04 USD/share | 0.92 USD/share | 0.39 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.